Keyphrases
18F-florbetaben
14%
Alzheimer
100%
Alzheimer's Disease
14%
Alzheimer's Disease Biomarkers
100%
Alzheimer's Disease Diagnosis
14%
Alzheimer's Disease Patient
14%
Amyloid Status
14%
AT(N)
100%
ATN Classification
14%
Barcelona
100%
Bland-Altman Analysis
14%
Brain Amyloidosis
14%
Chemiluminescent Enzyme Immunoassay (CLEIA)
71%
Clinical Diagnosis
14%
Cognitive Dementia
14%
Conversion Rate
14%
Cox Proportional Hazards Model
14%
CSF Biomarkers
28%
Dementia Conversion
14%
Dementia Patients
14%
Disease Progression
28%
Follow-up Data
14%
Immunodetection
14%
Intrinsic Variability
14%
Kaplan-Meier Analysis
14%
Kappa Agreement
28%
Lumipulse
28%
Memory Clinic
14%
Mild Cognitive Impairment
71%
N-categories
57%
Passing-Bablok
14%
Positron Emission Tomography
14%
Prognostic Value
28%
Real-life Cohort
14%
Spearman Coefficient
14%
Subjective Cognitive Decline
14%
Total tau
42%
Neuroscience
Alzheimer's Disease
100%
Amyloid Protein
20%
Amyloidosis
20%
Chemiluminescence
100%
ELISA
80%
Fluorine-18
20%
Immunoassay
100%
Mild Cognitive Impairment
100%
Positron Emission Tomography
20%
Subjective Cognitive Decline
60%
Pharmacology, Toxicology and Pharmaceutical Science
Alzheimer's Disease
100%
Amyloid Protein
14%
Amyloidosis
14%
Biological Marker
100%
Disease Exacerbation
28%
Enzyme Immunoassay
71%
Enzyme-Linked Immunosorbent Assay
57%
Florbetaben
14%
Mild Cognitive Impairment
71%
Immunology and Microbiology
Amyloidosis
20%
Chemoluminescence
100%
ELISA
80%
Enzyme Immunoassay
100%
Positron Emission Tomography
20%
Material Science
Chemiluminescence
100%
Tomography
20%